Hangzhou Xiaofu Technology Co., Ltd. announced that it has received $3,140,000 in funding led by Pharmaron Beijing Co., Ltd. on April 18, 2022. The transaction included participation from other investors.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.75 CNY | -1.00% | +8.70% | -31.85% |
04-30 | Pharmaron Beijing's Profit Rises 17% in 2023 | MT |
04-29 | Nomura Adjusts Pharmaron’s Price Target to 31.41 Yuan From 36.68 Yuan, Keeps at Buy | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.85% | 4.43B | |
+0.67% | 42.4B | |
+46.17% | 40.04B | |
-6.20% | 28.31B | |
+6.55% | 24.94B | |
-21.66% | 18.96B | |
+29.96% | 12.3B | |
-1.57% | 11.95B | |
+16.03% | 11.32B | |
-4.80% | 11.55B |
- Stock Market
- Equities
- 300759 Stock
- News Pharmaron Beijing Co., Ltd.
- Hangzhou Xiaofu Technology Co., Ltd. announced that it has received $3.140000 million in funding from Pharmaron Beijing Co., Ltd. and other investors.